Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David J Sher
ECOG-ACRIN Cancer Research Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
51 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Moffitt Cancer Center
Tampa, Florida, United States
- Moffitt Cancer Center - Mckinley Campus
Tampa, Florida, United States
- Moffitt Cancer Center-International Plaza
Tampa, Florida, United States
- Emory University Hospital Midtown
Atlanta, Georgia, United States
- Saint Luke'S Cancer Institute - Boise
Boise, Idaho, United States
- Saint Luke'S Cancer Institute - Fruitland
Fruitland, Idaho, United States
- Saint Luke'S Cancer Institute - Meridian
Meridian, Idaho, United States
- Saint Luke'S Cancer Institute - Nampa
Nampa, Idaho, United States
- Saint Luke'S Cancer Institute - Twin Falls
Twin Falls, Idaho, United States
- University of Illinois
Chicago, Illinois, United States
- Carle at the Riverfront
Danville, Illinois, United States
- Carle Physician Group-Effingham
Effingham, Illinois, United States
- Carle Physician Group-Mattoon/charleston
Mattoon, Illinois, United States
- Carle Cancer Center
Urbana, Illinois, United States
- Mission Cancer and Blood - Ankeny
Ankeny, Iowa, United States
- Mercy Hospital
Cedar Rapids, Iowa, United States
- Oncology Associates at Mercy Medical Center
Cedar Rapids, Iowa, United States
- Iowa Methodist Medical Center
Des Moines, Iowa, United States
- Mission Cancer and Blood - Des Moines
Des Moines, Iowa, United States
- Sanford Joe Lueken Cancer Center
Bemidji, Minnesota, United States
- Freeman Health System
Joplin, Missouri, United States
- Sands Cancer Center
Canandiaqua, New York, United States
- Highland Hospital
Rochester, New York, United States
- University of Rochester
Rochester, New York, United States
- Wilmot Cancer Institute Radiation Oncology at Greece
Rochester, New York, United States
- Stony Brook University Medical Center
Stony Brook, New York, United States
- Wilmot Cancer Institute at Webster
Webster, New York, United States
- Sanford Bismarck Medical Center
Bismarck, North Dakota, United States
- Sanford Broadway Medical Center
Fargo, North Dakota, United States
- Sanford Roger Maris Cancer Center
Fargo, North Dakota, United States
- Uh Seidman Cancer Center at Uh Avon Health Center
Avon, Ohio, United States
- Case Western Reserve University
Cleveland, Ohio, United States
- Uh Seidman Cancer Center at Lake Health Mentor Campus
Mentor, Ohio, United States
- University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
- Providence Newberg Medical Center
Newberg, Oregon, United States
- Providence Saint Vincent Medical Center
Portland, Oregon, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- Sanford Cancer Center Oncology Clinic
Sioux Falls, South Dakota, United States
- Sanford Usd Medical Center - Sioux Falls
Sioux Falls, South Dakota, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 Jun 2023
- Primary completion
- 31 Mar 2029
- Completion
- 31 Mar 2030
- Last update posted
- 10 Jul 2026
- Registered enrollment
- 290
- Registry id
- NCT05721755
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.